The Biotech Booster Acceleration Program organized by Business France encourages the international development of French innovations in healthcare to improve the patient’s access to disrupting new therapies.

Biotech Booster is a 3-step startup acceleration program for French companies in the field of Biotechnologies willing to develop in North America.

• No. 1 destination: United States (50% of subsidiaries)
• France is the leading healthtech listing in Europe
• 32% of French healthtech partnerships are with international players
• The North American continent is the most attractive region for French biotechs, with nearly 30% of international agreements signed

Source : France Biotech, Panorama France Healthtech 2021

1^st step – SELECTION (April 2022| Virtual)

• Pitch and Q&A session in front of a panel of North American experts including Biotech, Big Pharma, Centers of Excellence/Hospitals & Investors.
• Experts & Mentors: a jury of North American experts will select the companies participating to steps 2 & 3 of the program. These experts will support the delegation throughout the program.
• Laureates awards day (Paris): evening bringing together the French Biotech ecosystems with the presence of North Americans stakeholders.

2^nd step – BOOTCAMP – WORKSHOPS (June 2022 | Virtual)

• Workshops: learning sessions with North American experts regarding Pitch & Positioning, Regulatory & FDA, Market Access, Marketing & Communication, Fund Raising, Negotiation and Implantation.
• Coaching & Personalized 1:1 sessions with the aim to refine the participants’North-American strategy, as well as their product & solution presentations. They will be supported by regulatory, market access and communication experts.
• Feedback Meetings: pitch training during 1:1 meetings with Centers of Excellence/Hospitals Big Pharma & Investors.

3^rd step – ROADSHOW (26-30 September 2022 | Boston & Montreal)

• Business meetings to present the participants’ innovation to the North American market during B2B meetings with potential targeted clients, partners, decision-makers and KOLs from Biotech, Big Pharma, Centers of Excellence/Hospitals & Investors.
• Network & Pitch opportunity to gain visibility during events networking, pitch contests.
• Visits & Meetings todiscover major U.S. and Canadian stakeholders

LAUREATES 2022

The North American Selection Committee (USA & Canada) evaluates French startups during Pitch Session and selects the companies that will participate to the next steps (Bootcamp Workshops & Business Roadshow).

These experts also support companies and play a key role during the program.

Gabriela APIOU – Director Strategic Alliances at Massachusetts General Hospital Research Institute

Katie BODNER – Associate at 5AM Ventures

Khadija ELABID BASHLLARI – Senior Manager, Program and Alliance Management at Moderna

Kareem REDA – Chief Business Officer at ElevateBio

Brock REEVE – Executive Director at Harvard Stem Cell Institute

Julie YANG – VP at Bain Capital Life Sciences